The Equation Series
Menu

Healthcare · Profile from Healthcare Research Companion

Abridge AI, Inc.

The Pittsburgh-born ambient AI company that listens to the doctor–patient conversation and drafts the clinical note. It began as a consumer app for patients, pivoted to selling to health systems, became Epic's first ambient-documentation "Pal" in 2023, won the Kaiser Permanente rollout in 2024, raised more than $500m in 2025 at up to a ~$5.3bn valuation, and is now trying to turn a scribe into a "clinician intelligence" platform for coding, orders, prior authorization and trials, just as Epic ships its own scribe.

At a glance

Founded
March 2018, Pittsburgh, Pennsylvania (out of the Pittsburgh Health Data Alliance of UPMC, the University of Pittsburgh and Carnegie Mellon)
Founders
Shivdev (Shiv) Rao, MD (CEO; practising cardiologist, then at UPMC Enterprises); Sandeep Konam (CTO at founding); Florian Metze (CMU speech researcher, early chief scientist); sources differ on whether Zachary Lipton counts as a co-founder (he joined as adviser and later became CTO and chief scientist)
Headquarters
Pittsburgh (with offices in San Francisco and New York, reported)
Ownership / structure
Private, venture-backed; investors include Union Square Ventures, UPMC, Wittington Ventures, Spark Capital, Lightspeed, Redpoint, Bessemer, CVS Health Ventures, Kaiser Permanente Ventures, NVentures (Nvidia), CapitalG, IVP, Elad Gil, Andreessen Horowitz, Khosla; Epic reportedly holds an equity interest and a revenue share (reported, verify); Eli Lilly strategic investment (June 2026)
Leadership (2026)
Shiv Rao, co-founder and CEO; Zachary Lipton, CTO and chief scientist (also a CMU professor); Sagar Sanghvi, CFO (from January 2025); Brian Wilson, chief commercial officer (verify current titles)
Segment and buyer
Health IT / AI. Buyer is the health system (CMIO, CIO, CFO, CMO); users are physicians, advanced practice clinicians and, increasingly, nurses; payers and pharma are newer partners
Scale
"More than 150 health systems" and ~50m conversations a year (July 2025); "more than 300" enterprise systems representing ~250m patients (company claim, mid-2026); ~$100m ARR by May 2025 and ~$117m contracted ARR in Q1 2025 (third-party estimates, not company disclosure)
Capital raised / valuation
~$15m seed/Series A (2020); $12.5m Series A-1 (2022); $30m Series B (2023, ~$200m+ valuation, reported); $150m Series C (Feb 2024, ~$850m); $250m Series D (Feb 2025, ~$2.75bn); $300m Series E (June 2025, ~$5.3bn post-money; SEC Form D shows ~$316m sold, so a ~$316m "extension" reported in April 2026 appears to be the same round, not new money); no priced 2026 round reported, though Eli Lilly made an undisclosed strategic investment (June 2026); total raised ~$800m+ by mid-2026 (sources differ: ~$757m–$907m); secondary-market estimates of ~$5.7–6.0bn in 2026 (unconfirmed)
Signature moves (incl. failures)
Consumer "record your doctor" app (2020, abandoned as the core business); pivot to enterprise documentation (2021–22); University of Kansas Health System rollout (March 2023); first Epic ambient "Pal" (August 2023); Kaiser Permanente systemwide deal (August 2024); $550m of 2025 mega-rounds; move into coding, orders and real-time prior authorization (2025–26); the Sharp HealthCare consent lawsuit (filed late 2025, against a customer); Epic's own AI Charting and the platform pivot (2025–26); VA enterprise contract (September 2026)

9 strategic moves analysed

Each one gets a full strategy file in the companion: context, the decision, the financing, what happened, and the lesson.

  1. 2018

    Founding Pittsburgh Health Data Alliance

    Founding

  2. 2020

    Consumer Patient App Launch

    Launch / funding round

  3. 2022

    Enterprise Pivot and Kansas Rollout

    Pivot

  4. 2023

    Epic Pal Integration

    Partnership

  5. 2024

    Series C and Kaiser Permanente Deal

    Funding round / enterprise contract

  6. 2025

    Revenue Cycle and Prior Authorization

    AI launch / partnership

  7. 2025

    Series D and E Mega Rounds

    Funding round

  8. 2025

    Sharp Consent Lawsuit

    Litigation / regulatory risk

  9. 2026

    Epic Competition and Platform Pivot

    Strategy reset / AI launch